Page 41 - 南京医科大学自然版
P. 41
第45卷第11期 周锋盛,袁 琳,浦浙宁,等. 超声黏弹性成像瘤周参数对BI⁃RADS 4类乳腺结节良恶性的预测价值[J].
2025年11月 南京医科大学学报(自然科学版),2025,45(11):1563-1571 ·1571 ·
[22] 黄淑念. 黏弹性及剪切波弹性定量参数联合 BI⁃RADS Ultrasound in Medicine,2025,41(2):136-140
分类量化评分诊断乳腺结节的价值探讨[D]. 百色:右 [25]曹钟毓,周 鸿,翟 蓓,等. 剪切波弹性成像联合超微
江民族医学院,2024 血管成像对BI⁃RADS 4类乳腺结节的诊断价值[J]. 成
HUANG S N. The value of viscoelastic and shear⁃wave 都医学院学报,2024,19(6):958-961
elastic parameter combined with BI ⁃ RADS quantified CAO Z Y,ZHOU H,ZHAI B,et al. Value of shear wave
score in the diagnosis of breast nodules[D]. Baise:Youji⁃ elastography combined with superb microvascular imaging
ang Medical College for Nationalities,2024 in the diagnosis of B⁃RADS4 breast nodule[J]. Journal of
[23] JIA W R,XIA S J,JIA X H,et al. Ultrasound viscosity Chengdu Medical College,2024,19(6):958-961
imaging in breast lesions:a multicenter prospective [26]李易凤,陈 武,刘晓芳,等. 剪切波弹性成像在乳腺结
study[J]. Acad Radiol,2024,31(9):3499-3510 节 BI⁃RADS 3、4a 类中的应用价值[J]. 中国超声医学
[24]梁汝娜,张瑾晖,井佳瑜,等. 基于常规超声与超声造影 杂志,2020,36(7):613-616
特征构建列线图对乳腺BI⁃RADS 4类病变风险预测的 LI Y F,CHEN W,LIU X F,et al. Application value of
研究[J]. 中国超声医学杂志,2025,41(2):136-140 shear⁃wave elastography in category BI⁃RADS 3 and 4a of
LI R N,ZHANG J H,JIN J Y,et al. Study on risk predic⁃ breast lesions[J]. Chinese Journal of Ultrasound in Medi⁃
tion of BI⁃RADS 4 breast lesions by constructing a nomo⁃ cine,2020,36(7):613-616
gram model based on conventional ultrasound and contrast⁃ [收稿日期] 2025-08-06
enhanced ultrasound features[J]. Chinese Journal of (本文编辑:蒋 莉)
(上接第1545页) itor of cyclin⁃dependent kinases controls DNA replication
against triple⁃negative breast cancer[J]. Chem Biol Inter⁃ by interaction with PCNA[J]. Nature,1994,369(6481):
act,2023,369:110260 574-578
[14]ZHU J R,WANG L,NIE X Y,et al. RBMS3⁃loss impedes [21]ZHANG C,WANG S F,LU X Q,et al. POP1 Facilitates
TRIM21⁃induced ubiquitination of ANGPT2 in an RNA⁃ proliferation in triple⁃negative breast cancer via m6A⁃
independent manner and drives sorafenib resistance in dependent degradation of CDKN1A mRNA[J]. Research
hepatocellular carcinoma[J]. Oncogene,2025,44(21): (Wash D C),2024,7:0472
1620-1633 [22]奚佩雯,胡 玥,张 旭,等. RBM7 在乳腺癌细胞
[15]ZHANG Q S,HAN S Q,ZHANG X Y,et al. Metformin en⁃ BT474 中的表达及其与 P21 的关系[J]. 南京医科大学
hances PD⁃L1 inhibitor efficacy in ovarian cancer by modu⁃ 学报(自然科学版),2020,40(2):160-165
lating the immune microenvironment and RBMS3 expres⁃ XI P W,HU Y,ZHANG X,et al. Expression of RBM7 in
sion[J]. FASEB J,2025,39(11):e70705 breast cancer cell line BT474 and its relationship with
[16]RUAN X L,LIU Y H,WANG P,et al. RBMS3⁃induced P21[J]. Journal of Nanjing Medical University(Natural
circHECTD1 encoded a novel protein to suppress the Sciences),2020,40(2):160-165
vasculogenic mimicry formation in glioblastoma multi⁃ [23]XI P W,ZHANG X,ZHU L,et al. Oncogenic action of the
forme[J]. Cell Death Dis,2023,14(11):745 exosome cofactor RBM7 by stabilization of CDK1 mRNA
[17]ENGELAND K. Cell cycle regulation :p53 ⁃ p21 ⁃ RB in breast cancer[J]. NPJ Breast Cancer,2020,6:58
signaling[J]. Cell Death Differ,2022,29(5):946-960 [24]XU F,XIA T,XU Q T,et al. RBMS2 chemosensitizes
[18]TICLI G,CAZZALINI O,STIVALA L A,et al. Revisiting breast cancer cells to doxorubicin by regulating BMF ex⁃
CDKN1A
the function of p21 in DNA repair:the influence of pression[J]. Int J Biol Sci,2022,18(4):1724-1736
protein interactions and stability[J]. Int J Mol Sci,2022, [25]XIA T,DAI X Y,SANG M Y,et al. IGF2BP2 drives cell
23(13):7058 cycle progression in triple ⁃ negative breast cancer by
[19]THANGAVELU L,ALTAMIMI A S A,GHABOURA N, recruiting EIF4A1 to promote the m6A ⁃ modified CDK6
et al. Targeting the p53⁃p21 axis in liver cancer:linking translation initiation process[J]. Adv Sci(Weinh),2024,
cellular senescence to tumor suppression and progres⁃ 11(1):e2305142
sion[J]. Pathol Res Pract,2024,263:155652 [收稿日期] 2025-07-27
[20]WAGA S,HANNON G J,BEACH D,et al. The p21 inhib⁃ (本文编辑:陈汐敏)

